C011 Coding and Documentation
DESCRIPTION
Tuition fee and ticket required for admission
Speakers in this session review key elements of coding and documentation relevant to the day-to-day practice of clinical dermatologists. Recent or imminent changes in rules and regulations are highlighted. Adequate time is available for numerous questions from the audience. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuous Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org
LEARNING OBJECTIVES
Code E/M visits and procedures correctly.
Apply current rules and guidelines to ensure that chart documentation accurately conveys what occurred and is also adequate to support the codes selected.
Describe recent and impending changes in coding and documentation guidelines.
SCHEDULE
9:00 PM
How to do Preauthorizations
Alexandra Flamm, MD, FAAD
9:30 PM
Coding Updates
Alexander Miller, MD, FAAD
10:00 PM
Coding with Modifiers
Kishwer S. Nehal, MD, FAAD
10:30 PM
Documentation Tricks to support medical necessity
Brad P. Glick, DO, MPH, FAAD
11:00 PM
Navigating the complex world of payer audits
Curtis Asbury, MD, FAAD
11:30 PM
E/M Coding and Modifier-25
Mollie A. MacCormack, MD, FAAD
SPEAKERS
Murad Alam, MD, FAAD
Curtis Asbury, MD, FAAD
Alexandra Flamm, MD, FAAD
Brad P. Glick, DO, MPH, FAAD
Mollie A. MacCormack, MD, FAAD
Alexander Miller, MD, FAAD
Kishwer S. Nehal, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Murad Alam, MD, FAAD
No financial relationships exist with ineligible companies.
Curtis Asbury, MD, FAAD
No financial relationships exist with ineligible companies.
Alexandra Flamm, MD, FAAD
No financial relationships exist with ineligible companies.
Brad P. Glick, DO, MPH, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Almirall – Speaker(Honoraria); Alumis – Investigator(Grants/Research Funding); American Academy of Dermatology – Board of Directors(No Compensation Received); American Osteopathic College of Dermatology – Speaker/Faculty Education(Honoraria); Amgen – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Apogee Therapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Arcutis, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); AstraZeneca – Investigator(Grants/Research Funding); Bausch Health – Speaker/Faculty Education(Honoraria); Bellus Medical – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria); Brickell Biotech, Inc. – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Cara Therapeutics – Investigator(Grants/Research Funding); Castle Biosciences, Inc – Advisory Board(Honoraria); Celgene – Investigator(Grants/Research Funding); ChemoCentryx – Investigator(Grants/Research Funding); Clexio Biosciences, Ltd – Investigator(Grants/Research Funding); CoreEvitas, LLC – Investigator(Grants/Research Funding); Corrona, Inc. – Investigator(Grants/Research Funding); Derm Education Foundation – Speaker/Faculty Education(Honoraria); Dermavant Sciences, Inc. – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker(Fees); Dermira – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Evelo Biosciences, Inc. – Advisory Board(Other Financial Benefit); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Speaker(Honoraria); Galderma USA – Speaker(Honoraria); Glick Skin Institute – Founder(Salary); GSI Clinical Research, LLC – Investigator(Grants/Research Funding); Incyte Corporation – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Innovaderm Research Inc. – Investigator(Grants/Research Funding); Janssen Biotech – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Speaker(Honoraria); Larkin Community Hospital Palm Springs Campus – Speaker/Faculty Education(Salary); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Fees); Leo Pharma Inc – Independent Contractor(Honoraria); LEO Pharma, US – Speaker(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Lyceum Health – Advisory Board(Honoraria); MC2 Therapeutics – Advisory Board(Honoraria); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); National Psoriasis Foundation – Speaker(Honoraria), Speaker/Faculty Education(Fees); Nimbus Therapeutics – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Speaker(Honoraria); Noven Pharmaceuticals – Consultant(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria), Speaker/Faculty Education(Fees); PEERView – Consultant(Honoraria); PER View – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Platinum Dermatology Partners – Stockholder Private Company(Stock Options); Prose – Investigator(Grants/Research Funding); RAPT Therapeutics – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Society of Dermatology Physician Assistants – Speaker/Faculty Education(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); TopMD – Stockholder(Stock); UCB – Advisory Board(Honoraria), Speaker/Faculty Education(Fees); University of Pennsylvania – Investigator(Grants/Research Funding); Vial – Advisory Board(Honoraria); Xencor – Investigator(Grants/Research Funding);
Mollie A. MacCormack, MD, FAAD
Biofrontera – Advisory Board(Fees);
Alexander Miller, MD, FAAD
No financial relationships exist with ineligible companies.
Kishwer S. Nehal, MD, FAAD
No financial relationships exist with ineligible companies.